Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Flashcards
Nonsteroidal Anti-Inflammatory Drugs
diverse group of drugs which inhibit to some extent the Cyclooxygenase enzymes
Large chemical diversity exists among the NSAIDs, not all the same
NSAID Mechanism of Action
- Inhibition of Cycloxygenase (COX)
- Cox-1
- Cox-2
Prastaglandins
- Local regulation of organ and tissue function
- local control of vasculature of blood flow
- Local control of GI environment
- Local control of platelets
- Local control of Renin release
- Exception:
- Endotoxemia resulting in systemic release of prostaglandin and systemic effects
- Lipopolysaccharides (LPS) release from gram negative bacteria
- Endotoxemia resulting in systemic release of prostaglandin and systemic effects
Prostaglandins:
Cox-1
- “Constitutive” enzyme
- Local regulation in most cases
- PGE
- vasodilation
- sensitization of nociceptors
- Enhance inflammation
- Fever
- Gastroprotection
- mucous secretion, bicarbonate secretion, increased blood flow, inhibition of acid secretion
- Increase renal blood flow through vasodilation
- PGE
Prostaglandins:
Cox-1
PGF2a
Necessary for parturition in most animals
Lutalyse used to scencronize cattle
Prostaglandins:
Cox-1
TBX
Thromboxane
Platelet aggregation, vasoconstriction
Prostaglandins:
Cox-2
- “Inducible” enzyme
- local regulation in most cases
-
PGE:
- vasodilation, sensitization of nociceptors, inflammation, fever, maintain patency of ductus areteriosis, ovulation
- Release of renin
-
PGI:
- Prostacyclin: antagonist to Thromboxane
- Produced in blood vessel walls resulting in vasodilation and inhibition of platelet aggregation
- Sensitizes nociceptors
- Gastroprotective similar to PGE
-
PGE and PGI:
- Renal effects also include tubular effects
- Increase renal blood flow (Dogs, +/- cats and horses)
- Tubular release:
- increased sodium excretion
- Renal effects also include tubular effects
Prostaglandins:
Cox-2
“Inducible” Enzyme
- Up-regulated in some types of inflammation
- Up-regulated in some types of pain
- Up-regulated in gastric healing
- Up-regulated in renal vasculature during renal hyptension
- Cox-2 expressed in neoplastic tissue
- Angiogenesis? Inflammation?
- Constitutively expressed:
- GI tract - gastroprotective
- Renal - maintain renal blood flow and tubular functions
Lipoxygenase (LOX)
- Catalyzes formation of Leukotrienes
- Effects:
- Vasocontristion (Antagonistic to PGs)
- Decreases blood flow
- Increase Gastric Acid Secretion
- Pro-Inflammatory
- Activation, recruitment, migration, and adhesion of inflammatory cells
- Increased cytokine production (TNF-a, IL-1B)
- Bronchoconstriction
- Does nonselective COX inhibition increase leukotriense by shifting the AA pathway?
- yes
- Vasocontristion (Antagonistic to PGs)
Aspirin Triggered Lipoxin (ATL)
- Potent anti-inflammatory action
- Stimulate gastroprotective effects
- Modulate T-cells and Macrophages
- Aspirin induces Lipoxin formation by Cox-2
- Product to Acetylated Cox-2, therefore Cox-2 inhibitors prevent formation and beneficial effects
Nociceptive Stimulation
Cox-2 is the primary driver for the pain pathway
Non-selective COX inhibitor
Effect Cox-1 and Cox-2 the same
Cox-2 Selective Inhibitor
Effects Cox-2 with no effect on Cox-1
Cox-2 Preferential Inhibitor
Cox-2 is mostly effected, but there are small effects on Cox-1
GI Tract Adverse Effects (AE) from NSAIDs
- Vomiting, Diarrhea
- Gastritis, enteritis, GIT ulceration, death
- Right Dorsal Colitis in Horses
- Direct irritation of GIT
- Inhibition of both Cox-1 and Cox-2 produce greatest GIT adverse effects
- Cox-2 selective and preferential NSAIDs have less GIT adverse effects compated to nonselective inhibitors
- Except when there are underlying GI lesions
- Cox-2 selective and preferential NSAIDs have less GIT adverse effects compated to nonselective inhibitors
- Are GI adverse effects to in part to increases LT formation?
- Nonselective Cox and Lox inhibitor have low GIT adverse effects despite lack of Cox-2 selectivity